AU2003215942A1 - Formulation and manufacturing process of solubilized aceclofenac soft capsules - Google Patents

Formulation and manufacturing process of solubilized aceclofenac soft capsules

Info

Publication number
AU2003215942A1
AU2003215942A1 AU2003215942A AU2003215942A AU2003215942A1 AU 2003215942 A1 AU2003215942 A1 AU 2003215942A1 AU 2003215942 A AU2003215942 A AU 2003215942A AU 2003215942 A AU2003215942 A AU 2003215942A AU 2003215942 A1 AU2003215942 A1 AU 2003215942A1
Authority
AU
Australia
Prior art keywords
aceclofenac
solubilized
formulation
manufacturing process
soft capsules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003215942A
Inventor
Dong-Hyun Cho
Young-Sig Gil
Seok-Cheon Hong
Hyun-Jong Shin
Chang-Hun Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea United Pharm Inc
Original Assignee
Korea United Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea United Pharm Inc filed Critical Korea United Pharm Inc
Publication of AU2003215942A1 publication Critical patent/AU2003215942A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003215942A 2002-11-23 2003-03-20 Formulation and manufacturing process of solubilized aceclofenac soft capsules Abandoned AU2003215942A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2002-0073301 2002-11-23
KR1020020073301A KR100397349B1 (en) 2002-11-23 2002-11-23 Solubilized aceclofenac, soft capsule using the same and manufacturing method thereof
PCT/KR2003/000533 WO2004047834A1 (en) 2002-11-23 2003-03-20 Formulation and manufacturing process of solubilized aceclofenac soft capsules

Publications (1)

Publication Number Publication Date
AU2003215942A1 true AU2003215942A1 (en) 2004-06-18

Family

ID=32388205

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003215942A Abandoned AU2003215942A1 (en) 2002-11-23 2003-03-20 Formulation and manufacturing process of solubilized aceclofenac soft capsules

Country Status (3)

Country Link
KR (1) KR100397349B1 (en)
AU (1) AU2003215942A1 (en)
WO (1) WO2004047834A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100588810B1 (en) * 2004-02-04 2006-06-12 주식회사 서흥캅셀 Soft capsule containing transparent solubilized glimepiride solution as core ingredient
KR101717672B1 (en) * 2015-12-03 2017-03-17 경성대학교 산학협력단 Injections or eye drops, and its preparation method for producing a homogeneous solution was formed by solubilizing poorly soluble active pharmaceutical ingredient

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2211074T3 (en) * 1998-04-28 2004-07-01 Russinsky Limited ACLOFENACO PREPARATION PROCEDURE.
KR100336090B1 (en) * 1998-06-27 2002-05-27 윤승원 Solid dispersed preparation of poorly water-soluble drug containing oil, fatty acid or mixture thereof
KR100332210B1 (en) * 1998-12-04 2002-04-12 조민호 Transdermal delivery matrix for anti-inflammatory agent
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
KR100433614B1 (en) * 2000-06-16 2004-05-31 주식회사 태평양 Transdermal Preparation Containing Hydrophilic or Salt-form Drug

Also Published As

Publication number Publication date
WO2004047834A1 (en) 2004-06-10
KR100397349B1 (en) 2003-09-13

Similar Documents

Publication Publication Date Title
AU2003245336A1 (en) Medical grasper and method of making
AU2003257550A1 (en) Soft capsule preparation
AU2003288999A1 (en) Display unit and method of fabricating display unit
AU2003275155A1 (en) Medical device components and processes for their manufacturing
AU2003214579A1 (en) Semiconductor device and method of manufacturing same
AU2003269423A1 (en) Semiconductor devices and methods of manufacture thereof
AU2003239527A1 (en) Process for manufacturing and using a stable formulation of sodium chlorite
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
AU2002347476A1 (en) El display device and method of manufacturing the same
AU2002246950A1 (en) Hydrocapsules and method of preparation
AU2003215942A1 (en) Formulation and manufacturing process of solubilized aceclofenac soft capsules
AU2003269810A1 (en) Pyrroloquinoline quinone drugs as a neuroprotectant and methods of use thereof
AU2003227789A1 (en) Inhalator and method of manufacturing same
SI1581258T1 (en) Pharmaceutical formulation and a method of making same
AU2003233947A1 (en) Method and agent for producing therapeutically active blood compositions
AU2003295713A1 (en) Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
AU2003224468A1 (en) Soft capsule containing cyclosporine and it's manufacturing process
AU2003292059A1 (en) Process for the preparation of a cosmetic active
AU2203301A (en) Implement and method of manufacturing it
AU2003242872A1 (en) Semiconductor device and method of manufacturing same
AU2003261900A1 (en) Method of designing physiologically active peptide and use thereof
AU2002953408A0 (en) Hydrogel preparation and process of manufacture
AU2003219825A1 (en) Devices and method of manufacture
AU2003287768A1 (en) Hydrogel preparation and process of manufacture thereof
AU2002350212A1 (en) Pharmaceutically active compounds and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase